Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Organigram Holdings Inc (OGI) NPV

Sell:1.82 CAD Buy:1.85 CAD Change: 0.06 CAD (3.37%)
Market closed |  Prices as at close on 13 August 2020 | Switch to live prices |
Sell:1.82 CAD
Buy:1.85 CAD
Change: 0.06 CAD (3.37%)
Market closed |  Prices as at close on 13 August 2020 | Switch to live prices |
Sell:1.82 CAD
Buy:1.85 CAD
Change: 0.06 CAD (3.37%)
Market closed |  Prices as at close on 13 August 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OrganiGram Holdings Inc, formerly Inform Exploration Corp, is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc is a licensed medical marijuana producer of dried cannabis and cannabis oil. The Company is permitted to possess, produce, sell, provide, ship, deliver, transport and destroy cannabis, cannabis plants (including plants and seeds) and cannabis oil, in conformity with cannabis Act. The Company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. The Company distributes its products mainly through the Company’s online store or by phone.

Contact details

Address:
35A English Dr
MONCTON
E1E 3X3
Canada
Telephone:
+1 (506) 3841571
Website:
https://www.organigram.ca/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
OGI
ISIN:
CA68620P1018
Market cap:
346.22 million CAD
Shares in issue:
194.51 million
Sector:
Pharmaceuticals
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Peter Amirault
    Independent Chairman of the Board
  • Gregory Engel
    Chief Executive Officer, Director
  • Derrick West
    Chief Financial Officer
  • Timothy Emberg
    Senior Vice President - Sales and Commercial Operations
  • Helen Martin
    Senior Vice President, Strategic, Legal Affairs Corporate Secretary
  • Jeffrey Purcell
    Senior Vice President - Operations Services
  • Matthew Rogers
    Vice President - Operations
  • Julie Chamberlain
    Vice President of Marketing
  • Cameron Bishop
    Vice President of Public Affairs and Stakeholder Relations
  • Paolo De Luca
    Chief Strategy Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.